Lower Urinary Tract Symptoms: Clinical Trials

2,605 trials for Lower Urinary Tract Symptoms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1511 completed, 394 unknown, 233 recruiting, 153 terminated. 1279 Not applicable, 230 Phase 3, 225 Phase 4, 214 Phase 2, 112 Phase 1.

By phase and status

PhaseTrialsStatus
Not applicable1279Completed 675, Unknown 216, Recruiting 152, Not yet recruiting 69, Terminated 62, Active not recruiting 56, Withdrawn 35, Enrolling by invitation 13, Suspended 1
Phase 3230Completed 171, Unknown 21, Terminated 20, Withdrawn 8, Not yet recruiting 4, Active not recruiting 3, Recruiting 3
Phase 4225Completed 141, Unknown 24, Terminated 22, Recruiting 14, Not yet recruiting 11, Withdrawn 11, Active not recruiting 2
Phase 2214Completed 139, Unknown 23, Terminated 20, Withdrawn 12, Recruiting 9, Active not recruiting 6, Not yet recruiting 5
Phase 1112Completed 78, Unknown 16, Terminated 8, Active not recruiting 4, Not yet recruiting 2, Recruiting 2, Withdrawn 2
Early Phase 118Completed 8, Unknown 4, Recruiting 2, Terminated 2, Suspended 1, Withdrawn 1

Follow Lower Urinary Tract Symptoms: new trials by email Literature Review of Lower Urinary Tract Symptoms trials Research Report on Lower Urinary Tract Symptoms

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
School-Based Bladder Health Intervention
Bladder Health Education - Urinary Dysfunction, Lower Urinary Tract Symptoms
Not applicableWithdrawnStanford University2028-01-012026-05-07
Defining the Safety and Efficacy of POSterIor Tibial NeRve StimulatiON in Children
Urgent PC - Overactive Bladder, Overactive Bladder Syndrome
Phase 4Not yet recruitingChi Dang Hornik502027-04-012026-06-17
Target Physiotherapy Versus Exercise Support Intervention for Bladder-bowel Dysfunction in Adolescents With Obesity
Target physiotherapy, Exercise support intervention, Usual obesity care - Bladder-Bowel Dysfunction, Obesity & Overweight
Not applicableNot yet recruitingUniversity of Lisbon2372027-01-042026-07-23
Peroneal Neuromodulation vs Pelvic Floor Exercises in OAB
Transcutaneous Peroneal Electrical Neuromodulation, Pelvic Floor Exercise - Overactive Bladder (OAB), Neuromodulation
Not applicableNot yet recruitingMarmara University602026-12-012026-08-26
Male Pelvic Floor Muscle Rehabilitation Exercises
Male Pelvic Floor Rehabilitation #1 - Erectile Dysfunction, Urinary Incontinence
Not applicableNot yet recruitingDream Video LLC1002026-12-012026-10-07
Long-Term Effectiveness and Safety of Sacral Neuromodulation With InterStim for Lower Urinary Tract Dysfunction
InterStim™ Sacral Neuromodulation System II - X - Overactive Bladder (OAB), Urgency Urinary Incontinence
Not yet recruitingFundación Santa Fe de Bogota17002026-12-012026-10-02
Clinical, Functional, and Therapeutic Characterization of Women With Urinary Incontinence and Analysis of Factors Associated With Treatment Response
Artificial intelligence clinical decision support model - Urinary Incontinence (UI)
Not yet recruitingJavier Pereira802026-12-012026-10-21
An Observational, Multinational, In Hospital Evaluation of Catheter Utilization Rates in Female Patients Using Indwelling Urinary Catheters and the PureWick™ Flex Female External Catheter Across Europe and the Middle East
PureWick™ Flex Female External Catheter (FFEC), Indwelling Urinary Catheter (IUC) - Urinary Incontinence, Limited Mobility
Not yet recruitingBecton, Dickinson and Company2402026-11-062026-09-01
Suzetrigine for Opioid-Sparing Postoperative Analgesia Following Transvaginal Pelvic Reconstructive Surgery
Suzetrigine, Opioid Analgesics (Tramadol or Oxycodone), Scheduled Acetaminophen and Ibuprofen - Pelvic Organ Prolapse (POP), Stress Urinary Incontinence (SUI)
Phase 4Not yet recruitingUniversity of California, Los Angeles1202026-11-012026-09-15
Predictive Value of Inflammatory Biomarkers for Mirabegron Response in Women With Overactive Bladder
Mirabegron (beta3-adrenoceptor agonist) - Overactive Bladder (OAB)
Not yet recruitingBagcilar Training and Research Hospital1152026-11-012026-10-05
Urotherapy Education for Families of Children With Duchenne Muscular Dystrophy
Urotherapy Education - Duchenne Muscular Dystrophy (DMD), Lower Urinary Tract Symptoms (LUTS)
Not applicableNot yet recruitingLokman Hekim University502026-11-012026-09-15
Improving Uroflowmetry Interpretability: Evaluating the Impact of Patient Reminder Systems
Patient reminder system - Pelvic Organ Prolapse, Urinary Incontinence
Not applicableRecruitingOhio State University1622026-11-012026-09-24
Strategy for Managing Urinary Incontinence With PRP
Plasma rich platelet injection, Blood test, cytobacteriological examination of urine - Urinary Incontinence, Platelet Rich Plasma
Not applicableNot yet recruitingGCS Ramsay Santé pour l'Enseignement et la Recherche412026-10-302026-09-22
Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease
mirabegron, Exercise-based behavioral therapy - Overactive Bladder, Parkinson Disease
Phase 4Not yet recruitingVA Office of Research and Development1462026-10-212026-10-19
HIFEM for Incontinence After Menopause High-Intensity Focused Electromagnetic (HIFEM)
Pelvic floor training as described in point a above, with the addition of HIFEM., Pelvic Floor exercises - Urinary Incontinence (UI)
Not applicableNot yet recruitingGöteborg University1002026-10-152026-09-15
How Well and Safely Does Lemborexant Work for People Who Wake up at Night to Urinate (LENS)
Lemborexant tablets, Placebo - Nocturia
Phase 4Not yet recruitingUniversity of Alberta352026-10-152026-09-25
Comparison of Home Versus Clinic Kegel Rehabilitation in Women With Urinary Incontinence in the Tabuk Region
Home -Based Kegel Trainer Exercises (Kegel Trainer Application) will be used by the participants at home for training the pelvic floor muscles over 9 levels., Clinic-Based Rehabilitation Program will consist of physiotherapist supervised pelvic floor strengthening exercises for the participant , 2 times per week for 3 months - Urinary Incontinence (UI)
Not applicableNot yet recruitingUniversity of Tabuk1002026-10-012026-09-25
Impact of Transcutaneous Electrical Nerve Stimulation on the Autonomic Nervous System in the Treatment of Overactive Bladder
heart rate variability assement - Overactive Bladder (OAB)
Not applicableNot yet recruitingCentre Hospitalier de Roubaix702026-10-012026-08-24
Motor Imagery-Assisted Pelvic Floor Muscle Training for Stress Urinary Incontinence in Postmenopausal Women
Pelvic Floor Muscle Training, Pelvic-Floor-Specific Kinesthetic Motor Imagery, Dominant-Hand Kinesthetic Motor Imagery - Stress Urinary Incontinence (SUI)
Not applicableRecruitingIstanbul Medipol University Hospital602026-09-282026-10-08
The Effect of Different Delivery Positions on Pelvic Floor Function.
Lithotomy position, Lateral Position, Upright Position - Stress Urinary Incontinence (SUI)
Not applicableNot yet recruitingPeking University People's Hospital19922026-09-202026-09-10

Showing 20 of 2605. Sign in to see all of them.

Narrower conditions

Urinary Incontinence (934)  ·  Urinary Bladder, Overactive (801)  ·  Urinary Incontinence, Stress (641)  ·  Urinary Incontinence, Urge (241)  ·  Prostatic Hyperplasia (186)  ·  Nocturia (131)  ·  Pelvic Organ Prolapse (99)  ·  Prostatic Neoplasms (75)  ·  Pelvic Floor Disorders (62)  ·  Fecal Incontinence (53)  ·  Multiple Sclerosis (49)  ·  Sexual Dysfunction, Physiological (40)  ·  Motor Activity (39)  ·  Urinary Bladder, Neurogenic (39)

Broader conditions

Pathological Conditions, Signs and Symptoms (2605)  ·  Signs and Symptoms (2601)  ·  Urological Manifestations (2595)  ·  Urogenital Diseases (2410)  ·  Male Urogenital Diseases (2397)  ·  Female Urogenital Diseases and Pregnancy Complications (2258)  ·  Female Urogenital Diseases (2254)  ·  Urologic Diseases (2212)  ·  Urination Disorders (1612)  ·  Urinary Bladder Diseases (875)  ·  Urinary Incontinence (658)  ·  Genital Diseases (353)  ·  Genital Diseases, Male (281)  ·  Prostatic Diseases (250)

Interventions

Solifenacin Succinate (107)  ·  mirabegron (87)  ·  Botulinum Toxins, Type A (78)  ·  Tolterodine Tartrate (69)  ·  fesoterodine (42)  ·  Tamsulosin (41)  ·  Suburethral Slings (29)  ·  oxybutynin (28)  ·  Surveys and Questionnaires (23)  ·  Exercise (21)  ·  Transcutaneous Electric Nerve Stimulation (20)  ·  Duloxetine Hydrochloride (19)  ·  darifenacin (19)  ·  Deamino Arginine Vasopressin (17)  ·  Biofeedback, Psychology (15)

Sponsors

Astellas Pharma Inc (50)  ·  Pfizer (33)  ·  Allergan (30)  ·  National Taiwan University Hospital (27)  ·  Cairo University (25)  ·  University Hospital, Ghent (21)  ·  Coloplast A/S (20)  ·  Ferring Pharmaceuticals (20)  ·  Riphah International University (20)  ·  Eli Lilly and Company (17)  ·  Far Eastern Memorial Hospital (17)  ·  University of California, San Francisco (17)  ·  Samsung Medical Center (15)  ·  Ain Shams University (14)  ·  MedtronicNeuro (14)

Countries

United States (830)  ·  Turkey (Türkiye) (245)  ·  Canada (162)  ·  France (150)  ·  United Kingdom (126)  ·  Spain (109)  ·  Germany (101)  ·  Egypt (96)  ·  Taiwan (95)  ·  Belgium (91)  ·  South Korea (91)  ·  Italy (85)  ·  Denmark (84)  ·  China (79)  ·  Brazil (67)

Top investigators

Kenneth Peters, MD (14)  ·  Kyu-Sung Lee, Ph.D (12)  ·  Ho-Hsiung Lin, PhD (11)  ·  Seyda Toprak Celenay (10)  ·  Hann-Chorng Kuo, M.D. (8)  ·  Rose Khavari, MD (8)  ·  Karen Noblett, MD (6)

Results publications

PMID 39704322, PMID 37160401, PMID 37888839, PMID 37811598, PMID 19941278, PMID 12559262, PMID 32378735, PMID 37070660, PMID 40709601, PMID 17049716, PMID 28754926, PMID 30288727, PMID 35881009, PMID 19937315, PMID 36148895, PMID 11857671, PMID 12811491, PMID 21344495, PMID 24246044, PMID 25623739, PMID 26337427, PMID 26573101, PMID 29873008, PMID 32769645, PMID 32791124, PMID 9083302, PMID 15014933, PMID 15227649, PMID 15540753, PMID 16406907, PMID 16804634, PMID 16942457, PMID 16985862, PMID 17905093, PMID 18499184, PMID 19302497, PMID 20018326, PMID 20035977, PMID 20093904, PMID 21293089, PMID 21367921, PMID 21944127, PMID 22258963, PMID 22415792, PMID 22464310, PMID 23036134, PMID 23218404, PMID 23389863, PMID 23608668, PMID 23611930

NIH funding

U10HD041261 (7), U10HD041267 (7), U10HD041250 (6), 2017 (5), U01HD041249 (5), 2008 (4), 2009 (4), 2015 (4), U10HD041263 (4), U10HD054214 (4), U10HD054215 (4), 2014 (3), 2016 (3), 2019 (3), U01DK097772 (3)